Just In
- 7 hrs ago Backless Dress: 7 Tips For Choosing Perfect Bra For Backless Outfits And Turn Heads Wherever You Go
- 16 hrs ago Summer Style: 6 Must-Try Colors To Stay Fashionably Cool Like B-Town Divas!
- 18 hrs ago Belgian Man Cleared Of Drunk Driving Because His Body Produces Alcohol Due To A Rare Condition
- 18 hrs ago Amitabh Bachchan's Youthful Avatar In Kalki 2898 AD Is Impressive, Check Actors Who Sported Digital De-Aging!
Don't Miss
- Sports Manchester United star Rasmus Hojlund ignores Al Nassr star Cristiano Ronaldo to name English legend as his dream partner
- Finance Biggest Ever Stock Splits, 49 New Shares On Existing 1 Share; FMCG Makes Big Announcement Before Splitting
- Education JEE Main Result 2024 Out, Telangana's 15 Toppers Shine, Check Statewise List of 56 Candidates with Perfect 100
- News Mangalsutra Row: Did Indira Gandhi Donate Gold During The 1962 War? The Facts Behind Priyanka's Claim
- Movies Kota Factory 3 OTT Release Date, Platform: When Will Jitendra Kumar's Web Series Premiere On Netflix?
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
- Technology OPPO Find X7 Ultra Camera Deep-Dive: Pushing the Boundaries of Photography on a Smartphone
- Automobiles Aston Martin Vantage Launched In India At Rs 3.99 Crore
Omicron Can Evade Protection Offered By COVID-19 Vaccines, Antibody Therapies: Study
Omicron can evade the immune protection conferred by COVID-19 vaccines and natural infection, according to a peer-reviewed study which also suggests that the new variant of coronavirus is completely resistant to antibody therapies in use today.
The study, published in the journal Nature on Thursday, also highlights the need for new vaccines and treatments that anticipate how the SARS-CoV-2 virus may soon evolve.
The researchers from Columbia University in the US and the University of Hong Kong noted that a striking feature of Omicron is the alarming number of changes in the variant's spike protein that could pose a threat to the effectiveness of current vaccines and therapeutic antibodies.
The study tested the ability of antibodies generated by vaccination to neutralise Omicron in laboratory tests that pitted antibodies against live viruses and against pseudoviruses constructed in the lab to mimic the variant.
The researchers found that the antibodies from people double-vaccinated with Moderna, Pfizer, AstraZeneca, and Johnson & Johnson COVID-19 vaccines were significantly less effective at neutralising Omicron compared to the original virus.
Antibodies from previously infected individuals were even less likely to neutralise Omicron, they said.
People who received a booster shot of either Pfizer or Moderna vaccines are likely to be better protected, although even their antibodies exhibited diminished neutralising activity against Omicron, the study shows.
"The new results suggest that previously infected individuals and fully vaccinated individuals are at risk for infection with the Omicron variant," said David Ho, a professor at Columbia University Vagelos College of Physicians and Surgeons.
"Even a third booster shot may not adequately protect against Omicron infection, but of course, it is advisable to get one, as you will still benefit from some immunity," Ho added.
The researchers noted that the findings are consistent with other neutralisation studies, as well as early epidemiological data from South Africa and the UK, which show the efficacy of two doses of the vaccines against symptomatic disease is significantly reduced against Omicron.
The study also suggests that all of the monoclonal antibody therapies currently in use and most in development are much less effective against Omicron.
Photo: FreePik
- healthXBB.1.16: Symptoms; Are Vaccines Useful? WHO Concerned Over Recent COVID Spike In India
- disorders cureCommon COVID Symptoms In Fully Vaccinated Individuals: What You Should Know
- wellnessMild COVID Linked To Life-Threatening Blood Clots, Increased Risk Of Cardiovascular Disease; Study
- wellnessCOVID-19 Variants In India: New COVID Variant May Pose Threat To Elderly People
- basicsCovid-19 Linked To Early Onset Of Periods: What You Need To Know
- wellnessCOVID XBB Variants Of Omicron In India: What You Should Know
- disorders cureNew Omicron Subvariant BQ.1 Detected In Maharashtra: What You Should Know
- disorders cureOmicron BF.7 In India, Risk Of Fresh Wave During Diwali: What You Should Know
- wellnessOld Age Is A Risk Factor For Pneumonia Due To The Omicron Variant: Study
- disorders cureWhat Is ‘Centaurus,’ New Fast-Spreading Covid Variant: Everything You Need To Know
- health75 Years Of Independence, 75 Days Of Free COVID Booster Shots; For Everyone Aged 18-59 From 15 July
- wellnessWhat Are The Health Risks Of Getting COVID The Second Or Third Time? 7 Important Points